Intra-Cellular Therapies
ITCI
#1494
Rank
ยฃ10.53 B
Marketcap
ยฃ98.89
Share price
0.00%
Change (1 day)
83.45%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ0.13 B426.56%
2024ยฃ24.89 M-40.94%
2023ยฃ42.15 M51.56%
2022ยฃ27.81 M16.21%
2021ยฃ23.93 M25.98%
2020ยฃ18.99 M-33.46%
2019ยฃ28.54 M2213.17%
2018ยฃ1.23 M-95.97%
2017ยฃ30.59 M29.42%
2016ยฃ23.63 M-65.91%
2015ยฃ69.33 M104.09%
2014ยฃ33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
MediciNova
MNOV
ยฃ1.03 Mยฃ1.08 M๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
ยฃ0 Mยฃ0.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.23 Mยฃ0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA